We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$5.77B
AUM Growth
-$254M
Cap. Flow
-$320M
Cap. Flow %
-5.55%
Top 10 Hldgs %
18.38%
Holding
461
New
36
Increased
100
Reduced
232
Closed
35

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$53.7M
2
WMT icon
Walmart Inc
WMT
+$47.9M
3
GD icon
General Dynamics
GD
+$44.6M
4
WHR icon
Whirlpool
WHR
+$43.4M
5
GILD icon
Gilead Sciences
GILD
+$40.2M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$46.7M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$44.2M
3
BMY icon
Bristol-Myers Squibb
BMY
+$42.1M
4
CVX icon
Chevron
CVX
+$38.8M
5
DEO icon
Diageo
DEO
+$27.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Industrials 11.91%
3 Technology 11.79%
4 Consumer Discretionary 9.7%
5 Financials 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COV
451
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-431,910
Closed -$44.2M
BFY
452
DELISTED
BlackRock New York Municipal Income Trust II
BFY
– –
-10,150
Closed -$149K
EVJ
453
DELISTED
Eaton Vance New Jersey Municipal Income Trust
EVJ
– –
-7,900
Closed -$97K
AGN
454
DELISTED
Allergan Inc
AGN
– –
-66,425
Closed -$14.1M
15 16 17 18
19

Similar funds

MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return

Sit Investment Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Sit Investment Associates held 461 positions worth $5.77B, down 4.2% from $6.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Sit Investment Associates withdrew a net $320M in Q1 2015, closing 35 positions and reducing 232 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $44.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sit Investment Associates opened a new position in AbbVie worth $52M.

  • Sit Investment Associates's largest Q1 2015 buy was AbbVie: 888,791 shares worth $52M.
  • Sit Investment Associates added most to Gilead Sciences in Q1 2015, an estimated $40.2M increase.
  • Sit Investment Associates's biggest Q1 2015 reduction was Qualcomm, cutting an estimated $46.7M.
  • Sit Investment Associates fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $44.2M.
  • Sit Investment Associates's ten largest holdings make up 18% of its $5.77B portfolio in Q1 2015.
  • Sit Investment Associates opened 36 new positions and closed 35 in Q1 2015.
  • Sit Investment Associates's portfolio value fell 4.2% quarter-over-quarter to $5.77B.

Based on Sit Investment Associates's 13F filing for Q1 2015, filed 30 Apr 2015.